Recurrent pregnancy loss evaluation combined with 24-chromosome microarray of miscarriage tissue provides a probable or definite cause of pregnancy loss in over 90% of patients
Open accessThe DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: Will the addition of 24-chromosome microarray analysis on miscarriage tissue combined with the standard American Society for Reproductive Medicine (ASRM) evaluation for recurrent miscarriage explain most losses? SUMMARY ANSWER: Over 90% of patients with recurrent pregnancy loss (RPL) will have a probable or definitive cause identified when combining genetic testing on miscarriage tissue with the standard ASRM evaluation for recurrent miscarriage. WHAT IS KNOWN ALREADY: RPL is estimated to occur in 2-4% of reproductive age couples. A probable cause can be identified in approximately 50% of patients after an ASRM recommended workup including an evaluation for parental chromosomal abnormalities, congenital and acquired uterine anomalies, endocrine imbalances and autoimmune factors including antiphospholipid syndrome. STUDY DESIGN, SIZE, DURATION: Single-center, prospective cohort study that included 100 patients seen in a private RPL clinic from 2014 to 2017. All 100 women had two or more pregnancy losses, a complete evaluation for RPL as defined by the ASRM, and miscarriage tissue evaluated by 24-chromosome microarray analysis after their second or subsequent miscarriage. PARTICIPANTS/MATERIALS, SETTING, METHODS: Frequencies of abnormal results for evidence-based diagnostic tests considered definite or probable causes of RPL (karyotyping for parental chromosomal abnormalities, and 24-chromosome microarray evaluation for products of conception (POC); pelvic sonohysterography, hysterosalpingogram, or hysteroscopy for uterine anomalies; immunological tests for lupus anticoagulant and anticardiolipin antibodies; and blood tests for thyroid stimulating hormone (TSH), prolactin and hemoglobin A1c) were evaluated. We excluded cases where there was maternal cell contamination of the miscarriage tissue or if the ASRM evaluation was incomplete. A cost analysis for the evaluation of RPL was conducted to determine whether a proposed procedure of 24-chromome microarray evaluation followed by an ASRM RPL workup (for those RPL patients who had a normal 24-chromosome microarray evaluation) was more cost-efficient than conducting ASRM RPL workups on RPL patients followed by 24-chromosome microarray analysis (for those RPL patients who had a normal RPL workup). MAIN RESULTS AND THE ROLE OF CHANCE: A definite or probable cause of pregnancy loss was identified in the vast majority (95/100; 95%) of RPL patients when a 24-chromosome pair microarray evaluation of POC testing is combined with the standard ASRM RPL workup evaluation at the time of the second or subsequent loss. The ASRM RPL workup identified an abnormality and a probable explanation for pregnancy loss in only 45/100 or 45% of all patients. A definite abnormality was identified in 67/100 patients or 67% when initial testing was performed using 24-chromosome microarray analyses on the miscarriage tissue. Only 5/100 (5%) patients, who had a euploid loss and a normal ASRM RPL workup, had a pregnancy loss without a probable or definitive cause identified. All other losses were explained by an abnormal 24-chromosome microarray analysis of the miscarriage tissue, an abnormal finding of the RPL workup, or a combination of both. Results from the cost analysis indicated that an initial approach of using a 24-chromosome microarray analysis on miscarriage tissue resulted in a 50% savings in cost to the health care system and to the patient. LIMITATIONS, REASONS FOR CAUTION: This is a single-center study on a small group of well-characterized women with RPL. There was an incomplete follow-up on subsequent pregnancy outcomes after evaluation, however this should not affect our principal results. The maternal age of patients varied from 26 to 45 years old. More aneuploid pregnancy losses would be expected in older women, particularly over the age of 35 years old. WIDER IMPLICATIONS OF THE FINDINGS: Evaluation of POC using 24-chromosome microarray analysis adds significantly to the ASRM recommended evaluation of RPL. Genetic evaluation on miscarriage tissue obtained at the time of the second and subsequent pregnancy losses should be offered to all couples with two or more consecutive pregnancy losses. The combination of a genetic evaluation on miscarriage tissue with an evidence-based evaluation for RPL will identify a probable or definitive cause in over 90% of miscarriages. STUDY FUNDING/COMPETING INTEREST(S): No funding was received for this study and there are no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: Not applicable.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other than the prognostic advantages, when used in combination with routine investigations into recurrent miscarriage, cytogenetic analysis of the pregnancy tissue have shown to provide a diagnosis in over 90% of couples.137”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [137]
Citations
Cites
1 retracted
RETIRED: Technical Update: Preimplantation Genetic Diagnosis and Screening
Dahdouh, E. M., Balayla, J., Audibert, F., Wilson, R. D., Audibert, F., Brock, J., Campagnolo, C., Carroll, J. C., Chong, K., Gagnon, A. L., et al. (2015) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30261-9 · Cited by 107
RetractedChromosomal microarray versus karyotyping for prenatal diagnosis
Wapner, R. J., Martin, C. L., Levy, B., Ballif, B. C., Eng, C. M., Zachary, J. M., Savage, M., Platt, L. D., Saltzman, D., Grobman, W. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203382 · Cited by 1,412 · cited 1×
“Previous investigators have demonstrated that the detection of genetic abnormalities in miscarriage tissue is significantly improved by CMA analysis compared to standard karyotype (Reddy et al., 2012; Wapner et al., 2012; Lo et al., 2014).”
BackgroundEvaluation and treatment of recurrent pregnancy loss: a committee opinion
(2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.06.048 · Cited by 1,308
Thrombophilic disorders and fetal loss: a meta-analysis
Rey, E., Kahn, S. R., David, M., & Shrier, I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12771-7 · Cited by 872
A cytogenetic study of 1000 spontaneous abortions
HASSOLD, T., CHEN, N., FUNKHOUSER, J., JOOSS, T., MANUEL, B., MATSUURA, J., MATSUYAMA, A., WILSON, C., Yamane, J. A., & JACOBS, P. A. (1980) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1980.tb00955.x · Cited by 676
Retrospective and prospective epidemiological studies of 1500 karyotyped spontaneous human abortions
Boué, J., Boué, A., & Lazar, P. (1975) · Teratology · doi:10.1002/tera.1420120103 · Cited by 661
Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage
Jauniaux, E. (2006) · Human Reproduction · doi:10.1093/humrep/del150 · Cited by 520 · cited 2×
“Although the presence of a particular abnormal test result does not prove that it caused the pregnancy losses in these patients, abnormalities in parental genetics, uterine anatomy, lupus anticoagulant, anticardiolipin antibodies, TSH and hemoglobin A1c are considered either probable or definite causes of RPL (Christi…”
BackgroundStray-Pedersen, B., & Stray-Pedersen, S. (1984) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(84)80164-7 · Cited by 483
Human aneuploidy: Incidence, origin, and etiology
Hassold, T., Abruzzo, M., Adkins, K., Griffin, D., Merrill, M., Millie, E., Saker, D., Shen, J., & Zaragoza, M. (1996) · Environmental and Molecular Mutagenesis · doi:10.1002/(sici)1098-2280(1996)28:3<167::aid-em2>3.0.co;2-b · Cited by 456
Frequency of factors associated with habitual abortion in 197 couples
Daya, S., & Stephenson, M. D. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58382-4 · Cited by 428
Research works printed but not linked: 2
- Brezina, 2013, Clinical Reproductive Medicine and Surgery: A Practical Guide, 1
- Moraes, 2005, Cytogenetic and molecular evaluation of spontaneous abortion samples, Rev Bras Ginecol Obstet, 27, 554
Cited by
Dimitriadis, E., Menkhorst, E., Saito, S., Kutteh, W. H., & Brosens, J. J. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00228-z · Cited by 702
Self-citationChavez-Badiola, A., Flores-Saiffe-Farías, A., Mendizabal-Ruiz, G., Drakeley, A. J., & Cohen, J. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.07.003 · Cited by 168
Sato, T., Sugiura-Ogasawara, M., Ozawa, F., Yamamoto, T., Kato, T., Kurahashi, H., Kuroda, T., Aoyama, N., Kato, K., Kobayashi, R., et al. (2019) · Human Reproduction · doi:10.1093/humrep/dez229 · Cited by 161
Recurrent MiscarriageGreen‐top Guideline No. 17
Regan, L., Rai, R., Saravelos, S., Li, T., & the Royal College of Obstetricians and Gynaecologists (2023) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17515 · Cited by 158
Ghafourian, M., Mahdavi, R., Jonoush, Z. A., Sadeghi, M., Ghadiri, N., Farzaneh, M., & Salehi, A. M. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00853-z · Cited by 141
Metadata
- Authors
- Popescu, F., Jaslow, C. R., & Kutteh, W. H.
- Affiliations
- Rhodes College (US)
- St. Jude Children's Research Hospital (US)
- Corresponding author
- Kutteh, W H
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-03-12
- Volume
- 33
- Issue
- 4
- Pages
- 579-587
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2794293654
- Cited by
- 141
- References
- 46
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 17 · 2023: 28 · 2022: 19 · 2021: 20 · 2020: 18 · 2019: 10 · 2018: 7
- FWCI
- 5.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Keywords
- recurrent pregnancy loss, miscarriage, uterine anomalies, antiphospholipid syndrome, lupus anticoagulant, anticardiolipin antibodies, thyroid function, prolactin, cost analysis, diagnostic yield, endometrial receptivity
- MeSH terms
- Abortion, Habitual, Adult, Chromosome Aberrations, Female, Genetic Testing, Humans, Karyotyping, Maternal Age, Middle Aged, Pregnancy, Pregnancy Outcome, Prospective Studies, Tissue Array Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recurrent pregnancy loss evaluation combined with 24-chromosome microarray of miscarriage tissue provides a probable or definite cause of pregnancy loss in over 90% of patients. https://app.cochat.ai/papers/10.1093/humrep/dey021
- The paper
- Popescu, F., Jaslow, C. R., & Kutteh, W. H. (2018). Recurrent pregnancy loss evaluation combined with 24-chromosome microarray of miscarriage tissue provides a probable or definite cause of pregnancy loss in over 90% of patients. Human Reproduction. https://doi.org/10.1093/humrep/dey021
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.